BTF acquired by bioMerieux
Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.
The new acquisition will make BTF's products more accessible to a wider distribution network.
Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.
Illumina appoints Susan Martin as General Manager, ANZ
Most recently, Martin served as Managing Director, Australia and New Zealand at Johnson &...
Monash University signs MOU with TGA Academic Outreach Program
The program fosters collaboration across research, knowledge exchange and education to support...
Report: Economic value of NATA accreditation estimated at $488–712m annually
A UTS report has explored the economic and social value of National Association of Testing...
